# Antimicrobial Adjuvants to Revert the Imbalance of Skin Microbiota for Improved Outcomes of Complicated Cutaneous Leishmaniasis Treatment in Ethiopia

> **NCT06695143** · PHASE3 · NOT_YET_RECRUITING · sponsor: **Institute of Tropical Medicine, Belgium** · enrollment: 180 (estimated)

## Conditions studied

- Leishmaniasis, Cutaneous

## Interventions

- **DRUG:** Fusidic Acid
- **OTHER:** Vehicle cream

## Key facts

- **NCT ID:** NCT06695143
- **Lead sponsor:** Institute of Tropical Medicine, Belgium
- **Sponsor class:** OTHER
- **Phase:** PHASE3
- **Study type:** INTERVENTIONAL
- **Status:** NOT_YET_RECRUITING
- **Start date:** 2025-04
- **Primary completion:** 2027-03
- **Final completion:** 2027-04
- **Target enrollment:** 180 (ESTIMATED)
- **Last updated:** 2024-11-19

## Collaborators

- [object Object]
- [object Object]

## Primary source

ClinicalTrials.gov registry: https://clinicaltrials.gov/study/NCT06695143

## Citation

> US National Library of Medicine, ClinicalTrials.gov registration NCT06695143, "Antimicrobial Adjuvants to Revert the Imbalance of Skin Microbiota for Improved Outcomes of Complicated Cutaneous Leishmaniasis Treatment in Ethiopia". Retrieved via AI Analytics 2026-06-02 from https://api.ai-analytics.org/clinical/NCT06695143. Licensed CC0.

---

*[Clinical trials dataset](/datasets/clinical-trials) · CC0 1.0*